MedPath

bevacizumab-800CW

Generic Name
bevacizumab-800CW
Clinical Trials
Related News

Thyroid Cancer and Central Lymph Node Metastases Detection Using Bevacizumab-IRDye800CW

Phase 1
Completed
Conditions
Thyroid Carcinoma
Surgery
Interventions
First Posted Date
2023-10-23
Last Posted Date
2024-08-22
Lead Sponsor
University Medical Center Groningen
Target Recruit Count
20
Registration Number
NCT06095362
Locations
🇳🇱

University Medical Center Groningen, Groningen, Netherlands

Safety and Feasibility of Immuno-OCT

Not Applicable
Not yet recruiting
Conditions
Colon Carcinoma
Barrett Esophagus
Gastrointestinal Dysplasia
Interventions
First Posted Date
2023-08-23
Last Posted Date
2024-03-20
Lead Sponsor
University Medical Center Groningen
Target Recruit Count
15
Registration Number
NCT06008522

Improvement of the Operative Outcome in Patients With Primary VEGF + Unifocal Breast Cancer or DCIS Through the Intraoperative Visualization of the Tumor Using Molecular Imaging and Bevacizumab-IRDye-800CW

Phase 2
Withdrawn
Conditions
Breast Cancer
Interventions
First Posted Date
2022-05-04
Last Posted Date
2022-05-04
Lead Sponsor
Technical University of Munich
Registration Number
NCT05359874

Targeted Fluorescence Imaging in AMD

Phase 1
Completed
Conditions
Age-Related Macular Degeneration
NAMD
Interventions
First Posted Date
2022-03-02
Last Posted Date
2024-12-06
Lead Sponsor
University Medical Center Groningen
Target Recruit Count
12
Registration Number
NCT05262244
Locations
🇳🇱

University medical center Groningen (UMCG), Groningen, Netherlands

Detection of PitNET Tissue During TSS Using Bevacizumab-800CW

Phase 1
Completed
Conditions
Pituitary Adenoma
Pituitary Macroadenoma
Pituitary Tumor
Interventions
Device: Molecular Fluorescence Endoscopy platform
First Posted Date
2019-12-30
Last Posted Date
2023-04-14
Lead Sponsor
University Medical Center Groningen
Target Recruit Count
20
Registration Number
NCT04212793
Locations
🇳🇱

University Medical Center Groningen, Groningen, Netherlands

Image Guided Surgery in Sinonasal Inverted Papilloma

Phase 1
Conditions
Molecular Fluorescence Imaging
Inverted Papilloma
Interventions
First Posted Date
2019-04-24
Last Posted Date
2021-05-03
Lead Sponsor
University Medical Center Groningen
Target Recruit Count
6
Registration Number
NCT03925285
Locations
🇳🇱

University Medical Center Groningen, Groningen, Netherlands

FLuoresence Image Guided Surgery With A VEGF-targeted Tracer in Soft-tissue Sarcomas in Humans Approach With Bevacizumab-IRDye 800CW

Phase 1
Completed
Conditions
Soft Tissue Sarcoma
Interventions
First Posted Date
2019-04-12
Last Posted Date
2020-01-28
Lead Sponsor
University Medical Center Groningen
Target Recruit Count
16
Registration Number
NCT03913806
Locations
🇳🇱

University Medical Center Groningen, Groningen, Netherlands

Detection of Early Esophageal Cancer by NIR-FME.

Phase 2
Conditions
Barrett Esophagus
Interventions
Diagnostic Test: Fluorescence endoscopy
First Posted Date
2019-03-15
Last Posted Date
2020-11-04
Lead Sponsor
University Medical Center Groningen
Target Recruit Count
60
Registration Number
NCT03877601
Locations
🇳🇱

University Medical Center Groningen, Groningen, Netherlands

Fluorescence Image Guided Surgery in Cholangiocarcinoma

Phase 1
Conditions
Hilar Cholangiocarcinoma
Interventions
Device: near infrared (NIR) fluorescence imaging
First Posted Date
2018-08-08
Last Posted Date
2021-04-28
Lead Sponsor
University Medical Center Groningen
Target Recruit Count
12
Registration Number
NCT03620292
Locations
🇳🇱

University Medical Center Groningen, Groningen, Netherlands

Fluorescence Endoscopy of Esophageal Carcinoma

Phase 1
Terminated
Conditions
Esophageal Cancer
Interventions
Device: Molecular Fluorescence Endoscopy platform
First Posted Date
2018-06-15
Last Posted Date
2024-04-16
Lead Sponsor
University Medical Center Groningen
Target Recruit Count
25
Registration Number
NCT03558724
Locations
🇳🇱

University Medical Center Groningen, Groningen, Netherlands

© Copyright 2025. All Rights Reserved by MedPath
HomeTerms & ConditionsPrivacy Policy